Question 1

Is Samarium-((153)Sm)-Lexidronam-Pentanatrium currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Samarium-((153)Sm)-Lexidronam-Pentanatrium has 1 active shortage notice across 1 country (Germany). Status is refreshed daily from official regulatory sources.

Question 2

Why is Samarium-((153)Sm)-Lexidronam-Pentanatrium in shortage?

Accepted Answer

Regulators attribute the current Samarium-((153)Sm)-Lexidronam-Pentanatrium shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Samarium-((153)Sm)-Lexidronam-Pentanatrium shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 31 Dec 2026 to 31 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Samarium-((153)Sm)-Lexidronam-Pentanatrium shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Samarium-((153)Sm)-Lexidronam-Pentanatrium shortage status

Where Samarium-((153)Sm)-Lexidronam-Pentanatrium is in shortage

Why Samarium-((153)Sm)-Lexidronam-Pentanatrium is in shortage

Frequently asked questions

Get alerted when Samarium-((153)Sm)-Lexidronam-Pentanatrium status changes